Abo Bibliothek: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Erscheint 6 Ausgaben pro Jahr

ISSN Druckformat: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Mucosal Drug Delivery: Membranes, Methodologies, and Applications

Volumen 21, Ausgabe 3, 2004, 62 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v21.i3.20
Get accessGet access

ABSTRAKT

In recent years, extensive research into novel forms of drug delivery has suggested that mucosal approaches offer a promising therapeutic alternative, especially for systemically acting drugs. Transmucosal drug delivery offers many benefits, including noninvasive administration, convenience, rapid onset, as well as elimination of hepatic first-pass metabolism. The investigated absorptive surfaces consist of the nasal, buccal, ocular, vaginal, and rectal mucosae. Among these, the nasal and buccal routes have proved the most promising to date. The bioavailability achieved mainly depends upon the pathophysiological state of the mucosa and the properties of both the drug and delivery systems. Various agents can increase the efficacy of transmucosal drug delivery. These include cyclodextrins, bile salts, surfactants, fusidic acid derivatives, microspheres, liposomes, and bioadhesive agents.The mechanisms of action, effectiveness, and toxicity profiles of these enhancers have been investigated extensively in both animal and human models.

REFERENZIERT VON
  1. Turunen Elina, Mannila Janne, Laitinen Riikka, Riikonen Joakim, Lehto Vesa-Pekka, Järvinen Tomi, Ketolainen Jarkko, Järvinen Kristiina, Jarho Pekka, Fast-dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits, Journal of Pharmacy and Pharmacology, 63, 1, 2010. Crossref

  2. Vauthier Christine, Bertholon Isabelle, Labarre Denis, Integrated Development of Glycobiologics: from Discovery to Applications in the Design of Nanoparticular Drug Delivery Systems, in Pharmaceutical Sciences Encyclopedia, 2010. Crossref

  3. BONHAGE M. R., CHILCOAT C. D., LI Q., MELENDEZ V., FLOURNOY W. S., Evaluation of two scopolamine and physostigmine pretreatment regimens against nerve agent poisoning in the dog, Journal of Veterinary Pharmacology and Therapeutics, 32, 2, 2009. Crossref

  4. Sandri Giuseppina, Bonferoni Maria Cristina, Ferrari Franca, Rossi Silvia, Caramella Carla, Differentiating Factors between Oral Fast-Dissolving Technologies, American Journal of Drug Delivery, 4, 4, 2006. Crossref

  5. Chen Shu-Chih, Eiting Kristine, Cui Kunyuan, Leonard Alexis Kays, Morris Daniel, Li Ching-Yuan, Farber Ken, Sileno Anthony P., Houston Michael E., Johnson Paul H., Quay Steven C., Costantino Henry R., Therapeutic utility of a novel tight junction modulating peptide for enhancing intranasal drug delivery, Journal of Pharmaceutical Sciences, 95, 6, 2006. Crossref

  6. Luna E., Postol E., Caldas C., Benvenuti L. A., Rodrigues J. M., Lima K., Kalil J., Coelho V., Treatment with Encapsulated Hsp60 Peptide (p277) Prolongs Skin Graft Survival in a Murine Model of Minor Antigen Disparity, Scandinavian Journal of Immunology, 66, 1, 2007. Crossref

  7. Smart John D, Buccal drug delivery, Expert Opinion on Drug Delivery, 2, 3, 2005. Crossref

  8. Furubayashi Tomoyuki, Inoue Daisuke, Kamaguchi Akiko, Higashi Yutaka, Sakane Toshiyasu, Influence of Formulation Viscosity on Drug Absorption Following Nasal Application in Rats, Drug Metabolism and Pharmacokinetics, 22, 3, 2007. Crossref

  9. Singh Bhupinder, Pahuja Sonia, Kapil Rishi, Ahuja Naveen, Formulation development of oral controlled release tablets of hydralazine: Optimization of drug release and bioadhesive characteristics, Acta Pharmaceutica, 59, 1, 2009. Crossref

  10. Hu Longsheng, Damaj Bassam B., Martin Richard, Michniak-Kohn Bozena B., Enhanced in vitro transbuccal drug delivery of ondansetron HCl, International Journal of Pharmaceutics, 404, 1-2, 2011. Crossref

  11. Aşıkoğlu Makbule, Özgüney Işık, Özcan İpek, Örümlü Oya, Güneri Tamer, Köseoğlu Kamil, Özkılıç Hayal, The Absorption of99mTc-alendronate Given by Rectal Route in Rabbits, Pharmaceutical Development and Technology, 13, 3, 2008. Crossref

  12. Losso Jack, Development and Delivery of Anti-Angiogenic Functional Food Products, in Anti-Angiogenic Functional and Medicinal Foods, 20072347, 2007. Crossref

  13. Leonard Alexis Kays, Sileno Anthony P., Brandt Gordon C., Foerder Charles A., Quay Steven C., Costantino Henry R., In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo, International Journal of Pharmaceutics, 335, 1-2, 2007. Crossref

  14. Costantino Henry R., Illum Lisbeth, Brandt Gordon, Johnson Paul H., Quay Steven C., Intranasal delivery: Physicochemical and therapeutic aspects, International Journal of Pharmaceutics, 337, 1-2, 2007. Crossref

  15. Smart John D., Keegan Gemma, Buccal Drug Delivery Systems, in Oral Controlled Release Formulation Design and Drug Delivery, 2010. Crossref

  16. das Neves J., Bahia M.F., Gels as vaginal drug delivery systems, International Journal of Pharmaceutics, 318, 1-2, 2006. Crossref

  17. Peppas Nicholas A., Carr Daniel A., Impact of absorption and transport on intelligent therapeutics and nanoscale delivery of protein therapeutic agents, Chemical Engineering Science, 64, 22, 2009. Crossref

  18. Arima Hidetoshi, Motoyama Keiichi, Irie Tetsumi, Recent Findings on Safety Profiles of Cyclodextrins, Cyclodextrin Conjugates, and Polypseudorotaxanes, in Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine, 2011. Crossref

  19. Kong Bin, Sun Yong, Li Yongjian, Hu Dejian, Preparation and the Influencing Factors of Timozolomide Liposomes, Artificial Cells, Blood Substitutes, and Biotechnology, 37, 6, 2009. Crossref

  20. Maggio Edward T., Pillion Dennis J., High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers, Drug Delivery and Translational Research, 3, 1, 2013. Crossref

  21. Colombo P., Cagnani S., Buttini F., Santi P., Sonvico F., Russo P., Colombo G., Biological In Vitro Models for Absorption by Non-Oral Routes, in Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, 2013. Crossref

  22. Kumar Krishan, Dhawan Neha, Sharma Harshita, Vaidya Shubha, Vaidya Bhuvaneshwar, Bioadhesive polymers: Novel tool for drug delivery, Artificial Cells, Nanomedicine, and Biotechnology, 42, 4, 2014. Crossref

  23. He Biao, Zheng Bo-jian, Wang Qian, Du Lanying, Jiang Shibo, Lu Lu, Adenovirus-based vaccines against avian-origin H5N1 influenza viruses, Microbes and Infection, 17, 2, 2015. Crossref

  24. Poet Torka S., Timchalk Charles, Hotchkiss Jon A., Bartels Michael J., Chlorpyrifos PBPK/PD model for multiple routes of exposure, Xenobiotica, 44, 10, 2014. Crossref

  25. Ruggeri Matteo, Turriziani Adriana, Oradei Marco, Cost-effectiveness analysis of transnasal fentanyl citrate for the treatment of breakthrough cancer pain, Expert Review of Pharmacoeconomics & Outcomes Research, 14, 3, 2014. Crossref

  26. Johal Himmat Singh, Garg Tarun, Rath Goutam, Goyal Amit Kumar, Advanced topical drug delivery system for the management of vaginal candidiasis, Drug Delivery, 23, 2, 2016. Crossref

  27. Bouchal F., Skiba M., Chaffai N., Hallouard F., Fatmi S., Lahiani-Skiba M., Fast dissolving cyclodextrin complex of piroxicam in solid dispersion Part I: Influence of β-CD and HPβ-CD on the dissolution rate of piroxicam, International Journal of Pharmaceutics, 478, 2, 2015. Crossref

  28. Buccal Route and Ingestion, in Nanomedicines and Nanoproducts, 2015. Crossref

  29. Colombo P., Cagnani S., Sonvico F., Santi P., Russo P., Colombo G., Biological In Vitro Models for Absorption by Nonoral Routes, in Comprehensive Medicinal Chemistry II, 2007. Crossref

  30. Laffleur Flavia, Mucoadhesive therapeutic compositions: a patent review (2011-2014), Expert Opinion on Therapeutic Patents, 26, 3, 2016. Crossref

  31. Bonferoni Maria Cristina, Sandri Giuseppina, Rossi Silvia, Ferrari Franca, Caramella Carla, Chitosan and its salts for mucosal and transmucosal delivery, Expert Opinion on Drug Delivery, 6, 9, 2009. Crossref

  32. Yu Tao, Chisholm Jane, Choi Woo Jin, Anonuevo Abraham, Pulicare Sarah, Zhong Weixi, Chen Minmin, Fridley Colleen, Lai Samuel K., Ensign Laura M., Suk Jung Soo, Hanes Justin, Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces, Advanced Healthcare Materials, 5, 21, 2016. Crossref

  33. Mirza Mohd. Aamir, Panda Amulya K., Asif S., Verma Devina, Talegaonkar Sushama, Manzoor Nikhat, Khan Amber, Ahmed Farhan Jalees, Dudeja Mridu, Iqbal Zeenat, A vaginal drug delivery model, Drug Delivery, 23, 8, 2016. Crossref

  34. Battu Sunil Kumar, Repka Michael A., Majumdar Soumyajit, Rao Y Madhusudan, Formulation and Evaluation of Rapidly Disintegrating Fenoverine Tablets: Effect of Superdisintegrants, Drug Development and Industrial Pharmacy, 33, 11, 2007. Crossref

  35. Rohan L. C., Devlin B., Yang H., Microbicide Dosage Forms, in Microbicides for Prevention of HIV Infection, 383, 2013. Crossref

  36. Inoue Daisuke, Tanaka Akiko, Kimura Shunsuke, Kiriyama Akiko, Katsumi Hidemasa, Yamamoto Akira, Ogawara Ken-ichi, Kimura Toshikiro, Higaki Kazutaka, Yutani Reiko, Sakane Toshiyasu, Furubayashi Tomoyuki, The relationship between in vivo nasal drug clearance and in vitro nasal mucociliary clearance: Application to the prediction of nasal drug absorption, European Journal of Pharmaceutical Sciences, 117, 2018. Crossref

  37. Kaufman Paul L., Gabelt B’Ann True, Future of IOP-Lowering Medication for Glaucoma Therapy, in Glaucoma, 2006. Crossref

  38. Barbour Nancy P., Lipper Robert A., Introduction to Biopharmaceutics and its Role in Drug Development, in Biopharmaceutics Applications in Drug Development, 2008. Crossref

  39. Li Bi Lian, Yuen Vivian Man-ying, Zhang Na, Zhang Huan Huan, Huang Jun Xiang, Yang Si Yuan, Miller Jeffery W., Song Xing Rong, A Comparison of Intranasal Dexmedetomidine and Dexmedetomidine Plus Buccal Midazolam for Non-painful Procedural Sedation in Children with Autism, Journal of Autism and Developmental Disorders, 49, 9, 2019. Crossref

  40. Bykova A. F., Ivanov I. M., Grebenyuk A. N., PROBLEMS AND PROSPECTS OF INHALATION APPLICATION OF PEPTIDE AND PROTEIN COMPOUNDS AS POTENTIAL MEDICAL RADIATION PROTECTIVE AGENTS, Medicо-Biological and Socio-Psychological Problems of Safety in Emergency Situations, 2, 2018. Crossref

  41. Lalan Manisha S., Patel Vivek N., Misra Ambikanandan, Polymers in Vaginal Drug Delivery: Recent Advancements, in Applications of Polymers in Drug Delivery, 2021. Crossref

  42. Riaz Amina, Hendricks Sarah, Elbrink Kimberley, Guy Caljon, Maes Louis, Ahmed Naveed, Kiekens Filip, Khan Gul Majid, Preparation and Characterization of Nanostructured Lipid Carriers for Improved Topical Drug Delivery: Evaluation in Cutaneous Leishmaniasis and Vaginal Candidiasis Animal Models, AAPS PharmSciTech, 21, 5, 2020. Crossref

  43. Inoue Daisuke, Kimura Shunsuke, Kiriyama Akiko, Katsumi Hidemasa, Yamamoto Akira, Ogawara Ken-ichi, Higaki Kazutaka, Tanaka Akiko, Yutani Reiko, Sakane Toshiyasu, Furubayashi Tomoyuki, Quantitative Estimation of the Effect of Nasal Mucociliary Function on in Vivo Absorption of Norfloxacin after Intranasal Administration to Rats, Molecular Pharmaceutics, 15, 10, 2018. Crossref

  44. Furubayashi Tomoyuki, Inoue Daisuke, Kimura Shunsuke, Tanaka Akiko, Sakane Toshiyasu, Evaluation of the Pharmacokinetics of Intranasal Drug Delivery for Targeting Cervical Lymph Nodes in Rats, Pharmaceutics, 13, 9, 2021. Crossref

  45. Uchida Hiroshi, Kondoh Masuo, Hanada Takeshi, Takahashi Azusa, Hamakubo Takao, Yagi Kiyohito, A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide, Biochemical Pharmacology, 79, 10, 2010. Crossref

  46. Mura Paola, Maestrelli Francesca, Cirri Marzia, Mennini Natascia, Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review, Marine Drugs, 20, 5, 2022. Crossref

  47. Schmitt Laurenz, Marquardt Yvonne, Heise Ruth, von Felbert Verena, Amann Philipp M., Huth Laura, Steiner Timm, Hölzle Frank, Huth Sebastian, Baron Jens Malte, Novel Human Full-Thickness Three-Dimensional Nonkeratinized Mucous Membrane Model for Pharmacological Studies in Wound Healing, Skin Pharmacology and Physiology, 32, 5, 2019. Crossref

  48. Ammar H. O., Haider M., Ibrahim M., El Hoffy N. M., In vitro and in vivo investigation for optimization of niosomal ability for sustainment and bioavailability enhancement of diltiazem after nasal administration, Drug Delivery, 24, 1, 2017. Crossref

  49. Maeng Jeehye, Lee Kyunglim, Protein transduction domain of translationally controlled tumor protein: characterization and application in drug delivery, Drug Delivery, 29, 1, 2022. Crossref

  50. Epis Sara, Varotto-Boccazzi Ilaria, Manenti Alessandro, Rubolini Diego, Gabrieli Paolo, Cattaneo Giulia Maria, Gourlay Louise, Dapporto Francesca, Monti Martina, Razzano Ilaria, Leonardi Margherita, Iannacone Matteo, Recordati Camilla, Bertola Luca, Fiorina Paolo, Marvasi Luigi, Montomoli Emanuele, Zuccotti Gianvincenzo, Bandi Claudio, Efficacy of mucosal vaccination using a protozoan parasite as a vehicle for antigen delivery: IgG and neutralizing response after rectal administration of LeCoVax-2, a candidate vaccine against COVID-19, Pharmacological Research, 186, 2022. Crossref

  51. Inoue Daisuke, Yamashita Ayari, To Hideto, Development of In Vitro Evaluation System for Assessing Drug Dissolution Considering Physiological Environment in Nasal Cavity, Pharmaceutics, 14, 11, 2022. Crossref

  52. Alharbi Waleed S., Hareeri Rawan H., Bazuhair Mohammed, Alfaleh Mohamed A., Alhakamy Nabil A., Fahmy Usama A., Alamoudi Abdullah A., Badr-Eldin Shaimaa M., Ahmed Osama A., AlGhamdi Shareefa A., Naguib Marianne J., Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment, Pharmaceutics, 14, 12, 2022. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain